Home » Topics » Disease categories and therapies » Infection

Infection
RSS

InterMune begins phase II trial of Actimmune in cryptococcal meningitis

Feb. 4, 2000

Telithromycin featured in multiple presentations at ICMASKO 5

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

Pliva presents new azithromycin derivatives at ICMASKO 5

Feb. 3, 2000

BMS informs of first launch for new quinolone

Feb. 3, 2000

Potent, broad-spectrum cephalosporins in development at Roche

Feb. 3, 2000

Focus on carbapenem modifications continues at Merck

Feb. 3, 2000

Novel isatin derivatives with broad-spectrum antibacterial and antifungal activity

Feb. 3, 2000

Cerus continues phase III trial of platelet pathogen inactivation system in Europe

Feb. 3, 2000

Synthesis of TA-949, an orally active 1-beta-methylcarbapenem

Feb. 2, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...